Related Experiment Videos
Growth factors in bladder cancer
1Department of Urology and Cell Biology, The University of Texas, Houston 77030, USA.
World Journal of Urology
|January 1, 1995
Summary
This review covers peptide growth factors and their receptors involved in bladder cancer. It explores their role in signal-transduction pathways and potential diagnostic and therapeutic applications.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Peptide growth factors and their receptors are crucial in cellular processes.
- Aberrant signaling pathways involving growth factors are implicated in various cancers, including bladder cancer.
Purpose of the Study:
- To provide a comprehensive overview of peptide growth factors, their receptors, and associated signal-transduction pathways in bladder cancer.
- To discuss the potential of these molecules for diagnostic and therapeutic strategies in bladder cancer.
Main Methods:
- Literature review and synthesis of existing research on growth factors and bladder cancer.
- Detailed examination of specific growth factors: epidermal growth factor receptor (EGFR) and its ligands, erbB2, fibroblast growth factors (FGFs), insulin-like growth factor (IGF), transferrin receptor (TfR), and transforming growth factor-beta (TGF-β).
Main Results:
- Several growth factors and receptors, including EGFR, erbB2, FGFs, IGF, TfR, and TGF-β, are dysregulated in bladder cancer.
- These molecules activate specific signal-transduction pathways that promote tumor growth, proliferation, and metastasis.
- The identified pathways represent potential targets for novel therapeutic interventions.
Conclusions:
- Growth factors and their receptors are key players in bladder cancer pathogenesis.
- Targeting these pathways holds promise for developing innovative diagnostic tools and effective treatments for bladder cancer.